Literature DB >> 8873125

Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease.

Y Fukutani1, N J Cairns, M N Rossor, P L Lantos.   

Abstract

In order to elucidate further the pathological differences between familial Alzheimer's disease (FAD) and sporadic Alzheimer's disease (SAD), Purkinje cells and astrocytosis in the cerebellum of 10 FAD patients including two cases with the beta-amyloid precursor protein (APP) gene mutation in codon 717 (APP717 Val-->Ile), 10 SAD patients and 10 non-demented, age-matched controls were morphometrically investigated using immunohistochemistry. The regions examined included the molecular, Purkinje cell and granular cell layers, and the cerebellar white matter. This is the first report of a significantly decreased Purkinje cell density in FAD when compared to SAD. The density in SAD was also significantly decreased when compared to controls. In addition, the astrocyte density in FAD was significantly greater than that of SAD in the Purkinje cell layer, granular cell layer, and white matter. The density in SAD was also greater than that in controls, but not significantly in the granular cell layer and white matter. In the cases with the APP717 (Val-->Ile) mutation, Purkinje cell loss in the cerebellum was greater than the mean for FAD and SAD cases, while the astrocyte density was lower than the mean of all FAD cases, but higher than the mean of SAD cases. This study demonstrates that Purkinje cell loss and astrocytosis in FAD in the cerebellum are greater than in SAD, indicating that the cerebellum is more affected in FAD than in SAD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873125     DOI: 10.1016/0304-3940(96)12875-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Reduced Purkinje cell number in essential tremor: a postmortem study.

Authors:  Jordan E Axelrad; Elan D Louis; Lawrence S Honig; Ingrid Flores; G Webster Ross; Rajesh Pahwa; Kelly E Lyons; Phyllis L Faust; Jean Paul G Vonsattel
Journal:  Arch Neurol       Date:  2008-01

Review 2.  Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar Syndrome.

Authors:  Florian Bodranghien; Amy Bastian; Carlo Casali; Mark Hallett; Elan D Louis; Mario Manto; Peter Mariën; Dennis A Nowak; Jeremy D Schmahmann; Mariano Serrao; Katharina Marie Steiner; Michael Strupp; Caroline Tilikete; Dagmar Timmann; Kim van Dun
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

Review 3.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

4.  Cerebellar Volume Is Associated with Cognitive Decline in Mild Cognitive Impairment: Results from ADNI.

Authors:  Chi-Ying Lin; Chi-Hua Chen; Sarah E Tom; Sheng-Han Kuo
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

5.  Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brains.

Authors:  Elan D Louis; Phyllis L Faust; Jean-Paul G Vonsattel; Lawrence S Honig; Alex Rajput; Ali Rajput; Rajesh Pahwa; Kelly E Lyons; Webster G Ross; Rodger J Elble; Cordelia Erickson-Davis; Carol B Moskowitz; Arlene Lawton
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

Review 6.  Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice.

Authors:  Toshio Takeda
Journal:  Neurochem Res       Date:  2009-02-07       Impact factor: 3.996

7.  Network-selective vulnerability of the human cerebellum to Alzheimer's disease and frontotemporal dementia.

Authors:  Christine C Guo; Rachel Tan; John R Hodges; Xintao Hu; Saber Sami; Michael Hornberger
Journal:  Brain       Date:  2016-02-16       Impact factor: 15.255

8.  DNA damage and cell cycle events implicate cerebellar dentate nucleus neurons as targets of Alzheimer's disease.

Authors:  Jianmin Chen; Mark L Cohen; Alan J Lerner; Yan Yang; Karl Herrup
Journal:  Mol Neurodegener       Date:  2010-12-20       Impact factor: 14.195

9.  Early loss of cerebellar Purkinje cells in human and a transgenic mouse model of Alzheimer's disease.

Authors:  Kiran Chaudhari; Linshu Wang; Jonas Kruse; Ali Winters; Nathalie Sumien; Ritu Shetty; Jude Prah; Ran Liu; Jiong Shi; Michael Forster; Shao-Hua Yang
Journal:  Neurol Res       Date:  2021-03-10       Impact factor: 2.529

10.  Amyloid-beta induced CA1 pyramidal cell loss in young adult rats is alleviated by systemic treatment with FGL, a neural cell adhesion molecule-derived mimetic peptide.

Authors:  Nicola J Corbett; Paul L Gabbott; Boris Klementiev; Heather A Davies; Frances M Colyer; Tatiana Novikova; Michael G Stewart
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.